인벤테라

0007J0KOSDAQSector: Pharma & Biotech

₩7,060▼ 1.67%Market cap ₩55.5BAs of Jul 21, 2026 close · updated once daily

Grade C47.3 ptsTop 58% of 2,523 stocks

Financial strength

67.2

Price attractiveness

24.6

As of Jul 21, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

ⓘ Growth momentum not rated — will be included automatically as data accumulates

Financial strength

67.2

How much debt does it carry relative to equity?

Debt-to-equity ratio

8.1%

✓ Above median · Top 9.1% in sector

Sector median 51.5%

Can it cover what's due within a year?

Current ratio

2468.5%

✓ Above median · Top 3% in sector

Sector median 191.3%

How much did it earn on its own capital?

ROE (return on equity)

-56.4%

✗ Below median · Top 86.4% in sector

Sector median -4.5%

Source filing: annual report (separate) — view original ↗

Price attractiveness

24.6

Is the price expensive relative to earnings?

P/E (price-to-earnings)

Loss-making (P/E not computable)

✗ Below median · Top 77.8% in sector

Sector median P/E of profitable peers 14.4x · 57% loss-making

Is the price expensive relative to book value?

P/B (price-to-book)

3.89x

✗ Below median · Top 73% in sector

Sector median 1.39x

Valuation uses the Jul 21, 2026 close and market cap

Grade distribution of 248 stocks in Pharma & Biotech

S1A52B66C51D61F15